File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1136/jcp.2008.059477
- Scopus: eid_2-s2.0-61449163023
- PMID: 19181632
- WOS: WOS:000262918400008
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Development and validation of a ζ-globin-specific ELISA for carrier screening of the (--SEA) α thalassaemia deletion
Title | Development and validation of a ζ-globin-specific ELISA for carrier screening of the (--SEA) α thalassaemia deletion |
---|---|
Authors | |
Issue Date | 2009 |
Citation | Journal of Clinical Pathology, 2009, v. 62, n. 2, p. 147-151 How to Cite? |
Abstract | Aims: The Southeast Asian (SEA) deletion (--SEA) represents the most common determinant causing α thalassaemia in Southeast Asian countries. The embryonic ζ-globin chain has been defined as a marker for the detection of this deletion in adults. The aim of this study was to develop an appropriate low-cost ELISA for ζ-globin chain detection as a routine screening test for (--SEA) a thalassaemia deletion. Methods: A sandwich ELISA system for ζ-globin chains was established with a pair of ζ-globin-specific monoclonal antibodies prepared in-house, and locally made products. Against a gap-PCR method that was taken as the standard, this assay was validated in a cohort study testing a total of 526 individuals comprising patients scheduled for haemoglobinopathy diagnostic analysis and normal individuals. Routine screening of the (--SEA) deletion in 300 random student volunteers was conducted using the assay. Results: While the cut-off point was set at a percentage positive value of 30, the sensitivity and specificity of this ELISA method were 100% and 99.24%, respectively. The mean intra-assay and inter-assay coefficients of variation among the different concentrations in the optimised ELISA conditions were 2.1-11.4% and 4.3-13.2%, respectively. Seventeen of the 300 volunteers sampled were determined by the ELISA to have the (--SEA) deletion; these results were in 100% agreement with the gap-PCR results. Conclusions: This study validates the ELISA method described here as a simple, rapid and cost-effective assay that is potentially adaptable for application in large-scale population screening for this prevalent disorder in SEA areas such as southern China. |
Persistent Identifier | http://hdl.handle.net/10722/207910 |
ISSN | 2023 Impact Factor: 2.5 2023 SCImago Journal Rankings: 0.934 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Tang, L | - |
dc.contributor.author | Zhu, P | - |
dc.contributor.author | Zhou, WJ | - |
dc.contributor.author | Zheng, J | - |
dc.contributor.author | Zhou, YQ | - |
dc.contributor.author | Fu, N | - |
dc.contributor.author | Xu, XM | - |
dc.date.accessioned | 2015-01-26T11:46:42Z | - |
dc.date.available | 2015-01-26T11:46:42Z | - |
dc.date.issued | 2009 | - |
dc.identifier.citation | Journal of Clinical Pathology, 2009, v. 62, n. 2, p. 147-151 | - |
dc.identifier.issn | 0021-9746 | - |
dc.identifier.uri | http://hdl.handle.net/10722/207910 | - |
dc.description.abstract | Aims: The Southeast Asian (SEA) deletion (--SEA) represents the most common determinant causing α thalassaemia in Southeast Asian countries. The embryonic ζ-globin chain has been defined as a marker for the detection of this deletion in adults. The aim of this study was to develop an appropriate low-cost ELISA for ζ-globin chain detection as a routine screening test for (--SEA) a thalassaemia deletion. Methods: A sandwich ELISA system for ζ-globin chains was established with a pair of ζ-globin-specific monoclonal antibodies prepared in-house, and locally made products. Against a gap-PCR method that was taken as the standard, this assay was validated in a cohort study testing a total of 526 individuals comprising patients scheduled for haemoglobinopathy diagnostic analysis and normal individuals. Routine screening of the (--SEA) deletion in 300 random student volunteers was conducted using the assay. Results: While the cut-off point was set at a percentage positive value of 30, the sensitivity and specificity of this ELISA method were 100% and 99.24%, respectively. The mean intra-assay and inter-assay coefficients of variation among the different concentrations in the optimised ELISA conditions were 2.1-11.4% and 4.3-13.2%, respectively. Seventeen of the 300 volunteers sampled were determined by the ELISA to have the (--SEA) deletion; these results were in 100% agreement with the gap-PCR results. Conclusions: This study validates the ELISA method described here as a simple, rapid and cost-effective assay that is potentially adaptable for application in large-scale population screening for this prevalent disorder in SEA areas such as southern China. | - |
dc.language | eng | - |
dc.relation.ispartof | Journal of Clinical Pathology | - |
dc.title | Development and validation of a ζ-globin-specific ELISA for carrier screening of the (--SEA) α thalassaemia deletion | - |
dc.type | Article | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1136/jcp.2008.059477 | - |
dc.identifier.pmid | 19181632 | - |
dc.identifier.scopus | eid_2-s2.0-61449163023 | - |
dc.identifier.volume | 62 | - |
dc.identifier.issue | 2 | - |
dc.identifier.spage | 147 | - |
dc.identifier.epage | 151 | - |
dc.identifier.eissn | 1472-4146 | - |
dc.identifier.isi | WOS:000262918400008 | - |
dc.identifier.issnl | 0021-9746 | - |